Covaxin, jointly developed by Bharat Biotech and the state-funded Indian Council of Medical Research, was granted an import licence by Brazilian health regulator Anvisa in June this year. Earlier this month, the Brazilian parliamentary commission of inquiry started probing the transaction between Indian firm and India-Brazil Chamber of Commerce.
from Sputnik News - World News, Breaking News & Top Stories https://ift.tt/3hYt6is
Friday, July 23, 2021
India’s Bharat Biotech Terminates COVID-19 Vaccine Deal with Brazil Amid Kickback Allegations
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment